Share this post on:

Product Name :
Darunavir Ethanolate/Cobicistat

Search keywords :
Darunavir (Ethanolate)

drugId :
null

Target Vo:
Cytochrome P450 3A

Target Vo Short Name :
CYP3A

Moa_Name:
Human immunodeficiency virus type 1 protease inhibitors

First Approval Country :
EU

First Approval Date Filter:
2014

Origin Company_Name :
Johnson & Johnson Innovative Medicine

Active Company_Name :
Janssen-Cilag International Nv

Active Indication_Name:
HIV Infections

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
DXd Antibody (YA897)
KMT6/EZH2 Antibody
LRP1 Antibody: LRP1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 505 kDa, targeting to LRP1. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related